What Does MannKind Corporation Do?

Total employees576
HeadquartersDanbury
Founded1991

MannKind Corporation (NASDAQ: MNKD) is a biopharmaceutical company dedicated to the development and commercialization of innovative therapeutic products and devices for patients with endocrine and orphan lung diseases. Their flagship product, Afrezza® (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin approved in the United States for adults with diabetes. MannKind is also advancing a pipeline of other inhaled therapeutic candidates based on its proprietary Technosphere® inhalation technology, aiming to improve patient outcomes and convenience.

Where Is MannKind Corporation's Headquarters?

HQ Function

The Danbury facility serves as the main hub for MannKind's research and development, manufacturing of Afrezza® and Technosphere® particles, and corporate administrative functions.

Notable Features:

State-of-the-art manufacturing facilities specifically designed for producing their proprietary Technosphere® dry powder formulation and the Afrezza® product. Advanced R&D laboratories.

Work Culture:

The work culture at MannKind's headquarters emphasizes innovation, scientific rigor, collaboration, and a patient-centric approach. Employees are often engaged in cutting-edge biopharmaceutical research, development, and manufacturing processes.

HQ Significance:

This facility is crucial for MannKind as it houses the core capabilities for their Technosphere® platform, from R&D through to commercial-scale manufacturing, making it central to their business operations and future growth.

Values Reflected in HQ: The headquarters reflects MannKind's commitment to innovation in drug delivery, quality manufacturing, and scientific excellence in addressing unmet medical needs.

Location:

MannKind Corporation is primarily focused on the U.S. market with its lead product, Afrezza®. However, they actively pursue strategic partnerships and collaborations to expand the reach of their Technosphere® technology and pipeline products to global markets. Their global functions typically involve business development, seeking regulatory approvals in other regions through partners, and managing international collaborations for clinical development and commercialization.

Street Address:

1 Casper Street

City:

Danbury

State/Province:

CT

Country:

USA

Where Else Does MannKind Corporation Operate Around the World?

Westlake Village, CA, USA

Address: 30930 Russell Ranch Road, Suite 300, Westlake Village, CA 91362

Serves as a key corporate site, potentially housing executive leadership, business development, marketing, and other administrative teams, benefiting from California's biopharmaceutical ecosystem.

Buying Intent Signals for MannKind Corporation

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading MannKind Corporation? Meet the Executive Team

As of April 2025, MannKind Corporation' leadership includes:

Michael Castagna, Pharm.D. - Chief Executive Officer
Steven B. Binder - Executive Vice President, Chief Financial Officer
Burkhard Blank, Ph.D. - Executive Vice President, Research & Development and Chief Scientific Officer
David B. Thomson - Executive Vice President, Chief Commercial Officer
Kevin T. Kaiserman, M.D. - Chief Medical Officer
Chris Lowe - Executive Vice President, Chief Technical Officer

Who's Investing in MannKind Corporation?

MannKind Corporation has been backed by several prominent investors over the years, including:

BlackRock Inc.
The Vanguard Group, Inc.
State Street Corporation
Renaissance Technologies LLC
Geode Capital Management, LLC

What Leadership Changes Has MannKind Corporation Seen Recently?

Hire1
Exits0

MannKind Corporation has seen some leadership adjustments, primarily at the board level, to strengthen its strategic direction and governance over the past year. The core operational executive team has remained largely consistent.

New Appointments:

Dr. Thomas C. West, Dr. Thomas C. West joined the Board of Directors, enhancing the company's strategic oversight with his deep industry expertise.

What Technology (Tech Stack) Is Used byMannKind Corporation?

Discover the tools MannKind Corporation uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

MannKind Corporation Email Formats and Examples

MannKind Corporation likely utilizes common corporate email formats. The most probable format involves a combination of the employee's first initial and last name.

[first_initial][last]@mannkindcorp.com

Format

jdoe@mannkindcorp.com

Example

80%

Success rate

What's the Latest News About MannKind Corporation?

GlobeNewswireMarch 4, 2024

MannKind to Present New Data on Afrezza® and MNKD-101 at ATTD 2024

MannKind Corporation announced it will present new clinical and scientific data for Afrezza® (insulin human) Inhalation Powder and its investigational product candidate, MNKD-101 (clofazimine inhalation suspension), at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Florence, Italy....more

Business WireFebruary 28, 2024

MannKind Corporation Reports Fourth Quarter and Full-Year 2023 Financial Results

MannKind Corporation reported its financial results for the fourth quarter and full year ended December 31, 2023. Highlights include record total revenues and Afrezza net revenue, driven by strong demand and commercial execution....more

GlobeNewswireJanuary 4, 2024

MannKind Appoints Dr. Thomas C. West to its Board of Directors

MannKind Corporation announced the appointment of Thomas C. West, M.D., J.D., M.F.A., to its Board of Directors, effective January 2, 2024. Dr. West brings over 30 years of experience in the pharmaceutical industry....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including MannKind Corporation, are just a search away.